PharmaCyte Biotech (PMCB) Financials: Revenue & Earnings
PMCB$0.33-0.00 -0.60%
$3.57M
Market Cap
-0.14
P/E
—
Forward P/E
53
Score
PharmaCyte Biotech (PMCB) Financials: Revenue & Earnings
PMCB price $0.33 -0.00 -0.60%
- Ticker
- PMCB
- Price
- $0.33
- Change
- -0.00 -0.60%
- Market cap ?
- $3.57M
- P/E ?
- -0.14
- Dividend yield ?
- 0.00%
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 53
- Value
- 56
- Quality
- 52
- Growth
- 50
Stocklytics score rationale: value 56, quality 52, growth 50.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which utilizes cellulose to enclose live cells. This innovative platform…
Earnings and financials
PharmaCyte Biotech, Inc. (PMCB) trades at $0.33, with a market cap of $3.57M and a trailing P/E of -0.14. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insights · Dividends · Forecast · Financials · Learn